Alembic Pharmaceuticals Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	5,834	6,158	3,420	5,209	11,465
Depreciation & Amortization	2,786	2,727	2,754	2,868	1,835
Other Amortization	-	-	984.4	801.3	-
Loss (Gain) From Sale of Assets	-32.6	-17	47	-5.4	-13.9
Loss (Gain) From Sale of Investments	-4	-27.6	-1.4	-	-13.3
Loss (Gain) on Equity Investments	-8.7	9.8	309.2	-52.8	-
Provision & Write-off of Bad Debts	34.6	53.6	-	73	60.6
Other Operating Activities	1,484	84.8	301.7	303.6	-1,082
Change in Accounts Receivable	-3,950	390.5	-2,229	-4,696	5,109
Change in Inventory	-6,446	-1,683	1,344	-1,236	-2,986
Change in Accounts Payable	1,462	560.4	-281.7	366.7	452.7
Change in Other Net Operating Assets	-279.1	-224.6	590.5	1,892	-192.8
Operating Cash Flow	879.7	8,032	7,240	5,524	14,634
Operating Cash Flow Growth	-89.05%	10.95%	31.07%	-62.26%	225.82%
Capital Expenditures	-5,636	-3,275	-4,434	-4,256	-6,595
Sale of Property, Plant & Equipment	97.7	115.6	18.7	13.9	2.7
Investment in Securities	-211.3	-	-70	476.8	-1,861
Other Investing Activities	65.7	-47	9.5	46	65.3
Investing Cash Flow	-5,684	-3,206	-4,476	-3,720	-8,388
Short-Term Debt Issued	7,651	-	2,059	4,300	-
Total Debt Issued	7,651	-	2,059	4,300	-
Short-Term Debt Repaid	-	-2,054	-	-	-8,605
Long-Term Debt Repaid	-265.6	-258.2	-2,231	-3,202	-3,980
Total Debt Repaid	-265.6	-2,312	-2,231	-3,202	-12,585
Net Debt Issued (Repaid)	7,386	-2,312	-172.3	1,098	-12,585
Issuance of Common Stock	-	-	-	-	7,341
Common Dividends Paid	-2,162	-1,573	-1,966	-2,752	-
Other Financing Activities	-786.3	-493.9	-481.7	-519.7	-730.4
Financing Cash Flow	4,437	-4,379	-2,620	-2,174	-5,974
Foreign Exchange Rate Adjustments	-	-	-	-	-9.3
Miscellaneous Cash Flow Adjustments	-	0.1	-0.1	-	0.1
Net Cash Flow	-367.3	447.3	143.9	-369.7	262.2
Free Cash Flow	-4,757	4,757	2,805	1,267	8,039
Free Cash Flow Growth	-	69.58%	121.40%	-84.24%	-
Free Cash Flow Margin	-7.13%	7.64%	4.96%	2.39%	14.90%
Free Cash Flow Per Share	-24.20	24.20	14.27	6.45	41.49
Cash Interest Paid	785.9	493.7	497	519.2	729.4
Cash Income Tax Paid	714	198.5	607	1,234	2,454
Levered Free Cash Flow	-7,272	2,198	504.46	-324.73	4,359
Unlevered Free Cash Flow	-6,780	2,549	818.03	-213.91	4,459
Change in Working Capital	-9,214	-956.5	-575.6	-3,673	2,383

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.